Impact of Adding Integrated Neuromuscular Inhibition Technique to Postural Correction Exercises in Patients With Cervicogenic Headache

NCT ID: NCT07086898

Last Updated: 2025-07-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-30

Study Completion Date

2026-02-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

this study will be conducted to investigate the impact of adding integrated neuromuscular inhibition technique to postural correction exercises in patients with cervicogenic headache

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cervicogenic headache (CeH) is a secondary headache attributed to dysfunctions of the cervical spine. CGH is a non-throbbing, unilateral, side locked headache that originates in the cervical spine and gradually spreads to the occipital, temporal and orbital areas. It is associated with neck pain or stiffness and is often aggravated by sustained neck postures, repeated neck movements or physical activity. INIT is effective as it causes sustained or intermittent compression which causes ischemia reduces local circulation until pressure is released, after which a flushing of fresh oxygenated blood occurs. Mechanoreceptors impulses interface with slower pain messages reducing amount of pain messges reaching the brain, releasing pain relieving hormones, decreasing myofascial pain. Stretches the taut bands of muscles fibers. INIT along with strengthening excercises proved to be beneficial in decreasing disability improving Range of motion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervicogenic Headache

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

integrated neuromuscular inhibition technique and postural correction exercises
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
opaque sealed envelope

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Integrated Neuromuscular Inhibition Technique

Forty-five patients will receive integrated neuromuscular inhibition technique plus postural correction exercises three times a week for six weeks

Group Type EXPERIMENTAL

Integrated Neuromuscular Inhibition Technique

Intervention Type OTHER

Patients will receive integrated neuromuscular inhibition technique in the form of intermittent ischemic compression, strain counterstrain, and muscle energy technique plus postural correction exercises

Postural Correction Exercise

Intervention Type OTHER

The exercise program will be in the form of stretching exercises for the sternocleidomastoids (SCM), the scalenes, and upper fibers of trapezius; strengthening isometric exercises for the neck flexors, extensors, lateral flexors, and neck rotators; and postural correction exercises.

Postural Correction Exercise

Forty-five patients will receive postural correction exercises three times a week for six weeks

Group Type ACTIVE_COMPARATOR

Postural Correction Exercise

Intervention Type OTHER

The exercise program will be in the form of stretching exercises for the sternocleidomastoids (SCM), the scalenes, and upper fibers of trapezius; strengthening isometric exercises for the neck flexors, extensors, lateral flexors, and neck rotators; and postural correction exercises.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Integrated Neuromuscular Inhibition Technique

Patients will receive integrated neuromuscular inhibition technique in the form of intermittent ischemic compression, strain counterstrain, and muscle energy technique plus postural correction exercises

Intervention Type OTHER

Postural Correction Exercise

The exercise program will be in the form of stretching exercises for the sternocleidomastoids (SCM), the scalenes, and upper fibers of trapezius; strengthening isometric exercises for the neck flexors, extensors, lateral flexors, and neck rotators; and postural correction exercises.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 20 to 60 years old patient with unilaterally of the head pain
* pain triggered by external pressure over the upper cervical joints (c1-c3)
* pain elicited by the neck movements, and/or sustained awkward positions with reduced neck ROM
* headache intensity pain score of at least 20mm on the Visual analogue scale (VAS)
* headache frequency of at least once a week for at least 3 months
* minimum neck disability index score of 10 points or greater

Exclusion Criteria

* Migraine, tension- type headache, tumor, osteoporosis, fracture, rheumatoid arthritis and metabolic diseases.
* Prolonged history of steroid use.
* Resting blood pressure greater than 140/90 mmhg.
* cervical spinal stenosis, diminished sensation and central nervous system involvement,
* previous
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Al Shaymaa Shaaban Abd El Azeim

principle investigator : alshaymaa shaaban abd el azeim

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

alshaymaa abd elazeim, phd

Role: CONTACT

01033771553

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/005850

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cervicogenic Headache Dose-Response
NCT01530321 COMPLETED PHASE1/PHASE2